Lantronix. Buy, Sell or Hold?

In his Jan. 21 earnings preview, Roth Capital Markets analyst Scott Searle reiterated a “Buy” rating on Lantronix (Lantronix Stock Quote, Chart, News, Analysts, Financials NASDAQ:LTRX) and maintained his 12-month price target of $9.00.

Lantronix is an Irvine, California-based provider of networking, edge compute, and IoT connectivity solutions used to access, manage, and monitor mission-critical infrastructure across industrial, enterprise, and government markets.

Searle said recent developments, including CES and rising U.S. defence spending, continue to support a favourable long-term outlook, even as he modestly adjusted near-term revenue expectations following last fall’s 45-day U.S. federal government shutdown. He estimates the shutdown deferred roughly $2.5-million of revenue across three quarters but said the company’s strategic positioning continues to improve.

“CES combined with recent macro events continues to paint a favourable long-term outlook for LTRX,” Searle said, adding that the company remains well-positioned as an enabler of mission-critical infrastructure.

The analyst highlighted accelerating momentum in drones as a key near-term driver, with a longer-term pathway into robotics. Searle said Lantronix is seeing growing engagement around Qualcomm’s DragonWing platform, which he believes offers a power-efficiency advantage in inference-driven edge AI applications such as video analytics. Active drone engagements have now expanded to more than 17 manufacturers, up from 10 in the June quarter. He said management remains comfortable with FY26 drone revenue of $5-million to $10-million, with further ramp expected into FY27.

“Drone momentum continues to build and offers a clear migration path to robotics,” Searle said, noting that edge compute and visual AI capabilities should open opportunities across robotics, defence, law enforcement, and other commercial markets over time.

Searle also pointed to expanding annual recurring revenue opportunities tied to infrastructure monitoring. He highlighted a large deployment to equip and monitor more than 50,000 cell-site generators for a major U.S. Tier-1 wireless carrier, which he estimates could translate into $6-million+ of high-margin recurring revenue at full deployment, excluding one-time hardware sales. He added that Kompress.ai, Lantronix’s AI-enabled compressor monitoring platform, is tracking to early expectations and appears poised to expand geographically.

While trimming his near-term outlook, Searle said valuation remains attractive, with Lantronix trading at sub-2.0x EV/FY26E sales, well below peers with more established recurring-revenue models.

Searle now expects Lantronix to generate Adjusted EBITDA of $8.0-million on revenue of $124.1-million in fiscal 2026, revised from prior estimates, improving to Adjusted EBITDA of $16.2-million on revenue of $144.3-million in fiscal 2027.

 

-30-

Tagged with: ltrx
Tara Whittet

Tara Whittet is Senior Sales Manager at Cantech Letter.

Recent Posts

This pot stock will really benefit from rescheduling, analyst says

Beacon Securities analyst Russell Stanley maintained a “Buy” rating and C$17.00 target on Green Thumb Industries (Green Thumb Industries Stock… [Read More]

17 minutes ago

This analyst loves Hammond Power

Paradigm Capital analyst Razi Hasan initiated coverage of Hammond Power Solutions (Hammond Power Solutions Stock Quote, Chart, News, Analysts, Financials… [Read More]

18 hours ago

Don’t worry about these bad unemployment figures, RBC says

Royal Bank of Canada senior economist Claire Fan said in a May 8 report that Canada’s unemployment rate rose in… [Read More]

18 hours ago

This weed stock is undervalued, analyst says

Haywood analyst Neal Gilmer maintained a “Buy” rating and C$19.00 target on Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News,… [Read More]

18 hours ago

This analyst just upped his price target on Knight Therapeutics

Research Capital analyst Andre Uddin raised his target on Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:GUD)… [Read More]

3 days ago

Kinaxis is rolling, this analyst says

National Bank Financial analyst Richard Tse maintained Kinaxis (Kinaxis Stock Quote, Chart, News, Analysts, Financials TSX:KXS) as a Top Pick… [Read More]

3 days ago